InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Chesworth Richard, Directeur Scientifique. Director active across 2 companies, notably Kymera Therapeutics, Inc.. In total, 2 filings have been published. Activity tracked since 17 August 2021. The latest transaction was disclosed on 27 August 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Chesworth Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
33,779 shares@ US$20.0038.4% of flowCommon StockSEC:0001209191-21-053642:0
54,000 shares@ US$20.0061.6% of flowCommon StockSEC:0000899243-21-033638:0
2 of 2 declarations
About Chesworth Richard
Chesworth Richard is the Chief Scientific Officer of Kymera Therapeutics, Inc. In this role, he oversees the company's scientific research and development. His expertise is crucial for innovation and the development of new therapies within Kymera Therapeutics, Inc.
